What is the current Fecal Occult Blood (FOB) Test Kit market size?

The current Fecal Occult Blood (FOB) Test Kit market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Fecal Occult Blood (FOB) Test Kit market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Fecal Occult Blood (FOB) Test Kit market?

Key drivers include rising incidence of colorectal cancer and growing awareness of early detection methods.

What challenges does the Fecal Occult Blood (FOB) Test Kit market face?

Challenges include low awareness in developing regions and competition from alternative diagnostic methods.

Which regions are the leaders in the Fecal Occult Blood (FOB) Test Kit market?

North America and Europe are the leading regions, accounting for over 60% of the market share.

Who are the top companies in the Fecal Occult Blood (FOB) Test Kit market?

Top companies include Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers, offering a range of diagnostic solutions.

What future opportunities exist in the Fecal Occult Blood (FOB) Test Kit market?

Future opportunities include emerging markets and advancements in technology, such as point-of-care testing.

How will technology impact the Fecal Occult Blood (FOB) Test Kit market?

Technology will drive growth, with advancements in diagnostic accuracy and convenience, including digital and mobile health solutions.

What is the current regulatory landscape for the Fecal Occult Blood (FOB) Test Kit market?

The regulatory landscape is evolving, with increasing focus on safety and efficacy, driving the need for compliance and innovation.

What is the future outlook for the Fecal Occult Blood (FOB) Test Kit market?

The future outlook is positive, with growing demand and advancements in technology, driving growth and innovation in the market.

Fecal Occult Blood (FOB) Test Kit Market Potential & Strategic Outlook 2033

Fecal Occult Blood (FOB) Test Kit by Application (Hospital, Laboratory, Other), by Types (Colloidal Gold Method, Immunochromatography, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Fecal Occult Blood (FOB) Test Kit Market Size | CAGR 10.2 Forecast 2033

Fecal Occult Blood (FOB) Test Kit Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Fecal Occult Blood (FOB) Test Kit Market Overview

The Fecal Occult Blood (FOB) Test Kit market refers to the industry that produces and distributes kits used for the detection of hidden blood in feces, a common indicator of gastrointestinal disorders. The Fecal Occult Blood (FOB) Test Kit market size is estimated to be around $1.3 billion in 2025. As the market is expected to witness significant growth, driven by increasing awareness about colorectal cancer and other gastrointestinal disorders, the growth outlook and market forecast are crucial for industry players. The industry expansion is anticipated to be fueled by technological advancements, rising demand for non-invasive diagnostic tests, and growing healthcare expenditure. The scope of the market encompasses various types of FOB test kits, including guaiac-based, immunochemical, and molecular tests, used in hospitals, clinics, and laboratories.

Loading chart…

The Fecal Occult Blood (FOB) Test Kit market is expected to grow at a CAGR of around 7-8% during the forecast period from 2026 to 2033, driven by macro drivers such as increasing awareness about colorectal cancer, rising demand for non-invasive diagnostic tests, and growing healthcare expenditure. Key forces shaping the industry include technology shifts towards more accurate and sensitive testing methods, regulations promoting the use of FOB tests for colorectal cancer screening, and consumer behavior favoring non-invasive and self-testing options. The largest region in the FOB test kit market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare infrastructure and growing demand for diagnostic tests.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Actim; Abbott; CTK Biotech; Turklab; Epitope Diagnostics; SENTINEL; SureScreen Diagnostics; Xiamen Weizheng Biotechnology; Fuweil Biomedical; Aiwei Technology; Wanhua Puman Bioengineering; Wondfo Biotech; Chongqing Tianhai Medical; BioAssay Systems; Rapid Labs
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Fecal Occult Blood (FOB) Test Kit market is poised for significant growth, driven by increasing demand for early detection and prevention of colorectal cancer. The market dynamics are influenced by various factors, including technological advancements, regulatory requirements, and shifting consumer preferences.

Growth Drivers2 items

Advances in point-of-care testing technologies have improved the accuracy and convenience of FOB tests, leading to increased adoption rates and contributing to the growth forecast of the Fecal Occult Blood (FOB) Test Kit market size.

Government initiatives and awareness campaigns have boosted the demand for FOB tests, particularly in developing countries where access to healthcare services is limited, thereby driving the Fecal Occult Blood (FOB) Test Kit market.

Restraints2 items

The high cost of FOB tests and limited reimbursement options in some countries may hinder the growth of the Fecal Occult Blood (FOB) Test Kit market, making it challenging for manufacturers to expand their customer base.

Stringent regulatory requirements and the need for compliance with international standards may increase the operational costs for manufacturers, affecting the overall growth forecast of the Fecal Occult Blood (FOB) Test Kit market size.

Opportunities2 items

The increasing prevalence of colorectal cancer and the growing demand for non-invasive diagnostic tests present significant opportunities for manufacturers to develop innovative FOB tests and expand their market share in the Fecal Occult Blood (FOB) Test Kit market.

Partnerships and collaborations between manufacturers, research institutions, and healthcare providers can facilitate the development of new technologies and drive the growth of the Fecal Occult Blood (FOB) Test Kit market.

Challenges2 items

The Fecal Occult Blood (FOB) Test Kit market faces challenges from alternative diagnostic tests, such as DNA-based tests, which may offer higher accuracy and sensitivity, potentially affecting the market size and growth forecast.

Manufacturers must address concerns related to the environmental impact of FOB tests, such as the disposal of hazardous materials, to ensure sustainability and maintain a positive brand image in the Fecal Occult Blood (FOB) Test Kit market.

Market Segmentation

Loading chart…

The Application segment of the Fecal Occult Blood (FOB) Test Kit market refers to the various uses of these test kits in different settings. This segment contributes significantly to the overall Fecal Occult Blood (FOB) Test Kit market size, as it encompasses a wide range of applications, including clinical and home testing. Understanding the Fecal Occult Blood (FOB) Test Kit segmentation by application is crucial for market players to identify areas of growth and opportunities. The clinical application of FOB test kits is the largest segment, driven by the increasing prevalence of colorectal cancer and the need for early detection.

The Types segment of the Fecal Occult Blood (FOB) Test Kit market includes subtypes such as guaiac-based and immunochemical tests. This segmentation is essential for market players to understand the different technologies used in FOB test kits and their respective market shares. The guaiac-based tests are the traditional and most widely used type, while immunochemical tests are gaining popularity due to their higher sensitivity and specificity. Analyzing the market taxonomy of Fecal Occult Blood (FOB) Test Kit types helps companies to develop targeted strategies and invest in research and development to stay competitive.

Fecal Occult Blood (FOB) Test Kit Segmentation Breakdown8 items

Application

Hospital

Laboratory

Other

Types

Colloidal Gold Method

Immunochromatography

Other

Regional Insights

Loading chart…

The Fecal Occult Blood (FOB) Test Kit market growth is anticipated to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 40% of the global market share. The fastest-growing region is expected to be Latin America, driven by increasing adoption of FOB test kits, favorable policies, and rising investments in healthcare infrastructure.

Key drivers for each region include: for North America, demographics and ecosystem maturity; for Europe, policies and infrastructure; for Asia Pacific, adoption and investments; for Latin America, demographics and adoption; and for Middle East & Africa, infrastructure and ecosystem maturity. These factors will significantly influence the regional forecast and overall market growth.

Competitive Landscape

The Fecal Occult Blood (FOB) Test Kit market is moderately consolidated, with a mix of global players and local/regional companies competing for market share. The Fecal Occult Blood (FOB) Test Kit competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to have an advantage in terms of economies of scale and distribution networks, while local companies focus on regional expansion and customization to compete.

Companies in the FOB Test Kit market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on technology, service model, channel strength, customization, and cost advantages. The following companies have adopted distinct strategies:

Actim: regional expansion

Abbott: premium pricing

CTK Biotech: innovation pipeline

Turklab: local manufacturing

Epitope Diagnostics: OEM tie-ups

SENTINEL: vertical integration

Key Fecal Occult Blood (FOB) Test Kit Companies15 items

Actim

Abbott

CTK Biotech

Turklab

Epitope Diagnostics

SENTINEL

SureScreen Diagnostics

Xiamen Weizheng Biotechnology

Fuweil Biomedical

Aiwei Technology

Wanhua Puman Bioengineering

Wondfo Biotech

Chongqing Tianhai Medical

BioAssay Systems

Rapid Labs

Market Ecosystem

The Fecal Occult Blood (FOB) Test Kit ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. The ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where OEMs and manufacturers produce the test kits; and downstream, where distributors, channels, and end users interact. Value is created and captured at each stage, with technology providers and suppliers influencing the quality and features of the test kits, and end users driving demand through their purchasing decisions.

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — produce FOB test kits

Technology providers — develop underlying technologies

Distributors / channel partners — distribute test kits to end users

End users / buyers — purchase and use FOB test kits

Regulators/standards bodies — set standards and approve test kits

Service providers / after-sales — offer maintenance and support services

In the Fecal Occult Blood (FOB) Test Kit ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through approvals and standards. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact the production and distribution of test kits. Switching costs are relatively low, as end users can easily switch between different test kit brands. However, partnerships between OEMs and technology providers can create interoperability requirements, limiting the ability of end users to switch between different test kits. The ecosystem may differ by region, with varying regulatory requirements and standards influencing the production and distribution of test kits, highlighting the need for a thorough value chain analysis.

Recent Industry Insights

The Fecal Occult Blood (FOB) Test Kit industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key market players have focused on enhancing distribution networks and expanding product portfolios. Notably, the acquisition of Beckman Coulter by Danaher has strengthened the company's position in the Fecal Occult Blood (FOB) Test Kit market. Furthermore, the launch of innovative point-of-care testing solutions has improved diagnostic accuracy and convenience, driving growth in the Fecal Occult Blood (FOB) Test Kit industry trends. Regulatory changes, such as updated guidelines for colorectal cancer screening, have also contributed to the market's expansion.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Fecal Occult Blood (FOB) Test Kit market. The market attractiveness is moderate, driven by increasing demand for early cancer detection and prevention. The competitive intensity is high, with several key players competing for market share. Looking at the long-term outlook, the Fecal Occult Blood (FOB) Test Kit market outlook is expected to grow steadily, driven by advancements in technology and rising healthcare expenditures. The innovation landscape is characterized by ongoing research and development of more accurate and non-invasive testing methods.

The demand-supply balance is expected to be stable, with manufacturers increasing production to meet growing demand. However, key risk factors include regulatory changes, intense competition, and patent expirations. Overall, the market presents opportunities for growth and innovation, driven by the need for effective and early cancer detection methods. Decision-makers should focus on investing in research and development to stay competitive in this evolving market.

12 items

1. Executive Summary

2. Fecal Occult Blood (FOB) Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Fecal Occult Blood (FOB) Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Fecal Occult Blood (FOB) Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Fecal Occult Blood (FOB) Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Fecal Occult Blood (FOB) Test Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Fecal Occult Blood (FOB) Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Fecal Occult Blood (FOB) Test Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Fecal Occult Blood (FOB) Test Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Fecal Occult Blood (FOB) Test Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Fecal Occult Blood (FOB) Test Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Fecal Occult Blood (FOB) Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Fecal Occult Blood (FOB) Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Fecal Occult Blood (FOB) Test Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Fecal Occult Blood (FOB) Test Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Fecal Occult Blood (FOB) Test Kit Market Competition by Key Manufacturers

9.1. Global Fecal Occult Blood (FOB) Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Fecal Occult Blood (FOB) Test Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Actim

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Abbott

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. CTK Biotech

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Turklab

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Epitope Diagnostics

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. SENTINEL

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. SureScreen Diagnostics

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Xiamen Weizheng Biotechnology

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Fuweil Biomedical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Aiwei Technology

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Wanhua Puman Bioengineering

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Wondfo Biotech

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Chongqing Tianhai Medical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. BioAssay Systems

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Rapid Labs

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Fecal Occult Blood (FOB) Test Kit Market

Figure 4: Global Fecal Occult Blood (FOB) Test Kit Market: Drivers

Figure 5: Global Fecal Occult Blood (FOB) Test Kit Market: Challenges

Figure 6: Global Fecal Occult Blood (FOB) Test Kit Market: Trends

Figure 7: Global Fecal Occult Blood (FOB) Test Kit Market: Opportunity

Figure 8: Global Fecal Occult Blood (FOB) Test Kit Market: Restraint

Figure 9: Global Fecal Occult Blood (FOB) Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Fecal Occult Blood (FOB) Test Kit Market Value (USD Million) By Region

Figure 19: Global Fecal Occult Blood (FOB) Test Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Fecal Occult Blood (FOB) Test Kit Market Value (USD Million) By Region

Figure 27: Global Fecal Occult Blood (FOB) Test Kit Market Share (%) By: Regions (2032)

Figure 28: Global Fecal Occult Blood (FOB) Test Kit Market Volume (K) By Region

Figure 29: Global Fecal Occult Blood (FOB) Test Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Fecal Occult Blood (FOB) Test Kit Market Value (USD Million) By Region

Figure 37: Global Fecal Occult Blood (FOB) Test Kit Market Share (%) By: Regions (2032)

Figure 38: Global Fecal Occult Blood (FOB) Test Kit Market Volume (K) By Region

Figure 39: Global Fecal Occult Blood (FOB) Test Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Fecal Occult Blood (FOB) Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Fecal Occult Blood (FOB) Test Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Fecal Occult Blood (FOB) Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Fecal Occult Blood (FOB) Test Kit Market Value (USD Million) By Region

Table 14: Global Fecal Occult Blood (FOB) Test Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Fecal Occult Blood (FOB) Test Kit Market Volume (K) By Region

Table 31: Global Fecal Occult Blood (FOB) Test Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Fecal Occult Blood (FOB) Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Fecal Occult Blood (FOB) Test Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Fecal Occult Blood (FOB) Test Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Actim Basic Information And Sales Area

Table 52: Actim. Products Portfolio

Table 53: Abbott Basic Information And Sales Area

Table 54: Abbott. Products Portfolio

Table 55: CTK Biotech Basic Information And Sales Area

Table 56: CTK Biotech. Products Portfolio

Table 57: Turklab Basic Information And Sales Area

Table 58: Turklab. Products Portfolio

Table 59: Epitope Diagnostics Basic Information And Sales Area

Table 60: Epitope Diagnostics. Products Portfolio

Table 61: SENTINEL Basic Information And Sales Area

Table 62: SENTINEL. Products Portfolio

Table 63: SureScreen Diagnostics Basic Information And Sales Area

Table 64: SureScreen Diagnostics. Products Portfolio

Table 65: Xiamen Weizheng Biotechnology Basic Information And Sales Area

Table 66: Xiamen Weizheng Biotechnology. Products Portfolio

Table 67: Fuweil Biomedical Basic Information And Sales Area

Table 68: Fuweil Biomedical. Products Portfolio

Table 69: Aiwei Technology Basic Information And Sales Area

Table 70: Aiwei Technology. Products Portfolio

Table 71: Wanhua Puman Bioengineering Basic Information And Sales Area

Table 72: Wanhua Puman Bioengineering. Products Portfolio

Table 73: Wondfo Biotech Basic Information And Sales Area

Table 74: Wondfo Biotech. Products Portfolio

Table 75: Chongqing Tianhai Medical Basic Information And Sales Area

Table 76: Chongqing Tianhai Medical. Products Portfolio

Table 77: BioAssay Systems Basic Information And Sales Area

Table 78: BioAssay Systems. Products Portfolio

Table 79: Rapid Labs Basic Information And Sales Area

Table 80: Rapid Labs. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Fecal Occult Blood (FOB) Test Kit Market Value (USD Million) By Region

Table 90: Global Fecal Occult Blood (FOB) Test Kit Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global Fecal Occult Blood (FOB) Test Kit Market Volume (K) By Region

Table 107: Global Fecal Occult Blood (FOB) Test Kit Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Fecal Occult Blood (FOB) Test Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Actim; Abbott; CTK Biotech; Turklab; Epitope Diagnostics; SENTINEL; SureScreen Diagnostics; Xiamen Weizheng Biotechnology; Fuweil Biomedical; Aiwei Technology; Wanhua Puman Bioengineering; Wondfo Biotech; Chongqing Tianhai Medical; BioAssay Systems; Rapid Labs
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options